1 / 1

Understanding Antibiotic Resistance in Enterobacteriaceae: A Comprehensive Analysis

This study presents detailed prevalence data of antibiotic resistance genes in Enterobacteriaceae strains, such as E. coli, K. oxytoca, K. pneumoniae, and P. mirabilis. The findings shed light on the distribution of resistance mechanisms and their impact on public health.

jered
Download Presentation

Understanding Antibiotic Resistance in Enterobacteriaceae: A Comprehensive Analysis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Prevalence:0.85% E. coli: 35/3116 (1.12%) CMY-2 33 (1.05%) CMY-54 1 (0.03%) CMY-55 1 (0.03%) DHA-1 1 (0.03%) K. oxytoca: CMY-2 1/152 (0.6%) K. pneumoniae: CMY-2 1/330 (0.3%) P. mirabilis: CMY-2 4/473 (0.84%) Prevalence: 0.6% E. coli: CMY-2 17/3145 (0.54%) K. oxytoca: CMY-2 1/22 (4.55%) K. pneumoniae: CMY-2 1/65 (1.54%) P. mirabilis: CMY-2 6/212 (2.83%) Prevalence: 0.66% E. coli: 23/2402 (0.95%) CMY-2 21 (0.87%) CMY-4 1 (0.04%) CMY-7 1 (0.04%) P. mirabilis: CMY-2 3/167 (1.8%) Prevalence: 0.41% C. koseri: CMY-2 1/41 (2.4%) E. coli: 14/2987 (0.47%) CMY-2 13 (0.44%) DHA-1 1 (0.03%) P. mirabilis: CMY-2 2/352 (0.57%) P. penneri: CMY-2 1/1 Prevalence: 0.92% C. koseri: 3/34 (8.8%) DHA-1 2 (0.06%); ACC-1 + ACT-2 1 (0.03%) E. coli: 136/ 16059 (0.84%) ACC-1 3 (0.02%) CMY-2 96 (0.6%) CMY-4 1 CMY-27 2 CMY-48 1 DHA-1 30 (0.18%) DHA-6 1 FOX-3 1 VIM-1 1 K. oxytoca: 13/400 (3.25%) DHA-1 5 (1.25%) VIM-1 8 (2%) K. pneumoniae: 58/2412 (2.4%) ACC-1 3 (0.12%) CMY-2 3 (0.12%) CMY-56 2 (0.08%) DHA-1 48 (2%) VIM-1 3 (0.12%) P. mirabilis: 24/1710 (1.4%) ACC-1 3 (0.17%) CMY-2 18 (1.05%) DHA-1 3 (0.17%) Salmonella: DHA-1 1/28 (3.5%) E. cloacae: 6/209 (1.4%) VIM-1 4 (1.9%) DHA-7 + VIM-1 2 (0.95%) Prevalence:0.61% E. coli: 81/9539 (0.85%) CMY-2 79 (0.82%) CMY-43 1 (0.01%) DHA-1 1 (0.01%) K. pneumoniae: CMY-60 1/199 (0.5%) P. mirabilis: CMY-2 1/301 (0.33%) Prevalence:0.63% E. coli: 20/2804 (0.71%) CMY-2 18 (0.64%) DHA-1 2 (0.06%) K. pneumoniae: 3/343 (0.87%) CMY-2 1/343 (0.3%) DHA-1 2 (0.6%) P. mirabilis: CMY-2 4/372 (1%) Prevalence: 0% Prevalence: 0.5% E. coli: 81/12962 (0.62%) CMY-2 79 (0.60%) DHA-1 2 K. pneumoniae: 13/1651 (0.84%) CMY-2 5 (0.36%) DHA-1 3 (0.12%) VIM-1 5 (0.3%) K. oxytoca: 3/65 (4.61%) VIM-1 2 (3.07%) IMP-28 1 (1.53%) P. mirabilis: CMY-2 10/1414 (0.7%) E. cloacae: VIM-1 5/85 (5.88%) Prevalence: 0.47% E. coli: CMY-2 2/203 (0.99%) Prevalence: 0.47% E. coli: 12/1431 (0.83%) CMY-2 8 (0.56%) CMYt 3 (0.21%) DHA-1 1 (0.07%) K. pneumoniae: 15/237 (6.3%) CMY-2 1 (0.42%) DHA-1 10 (4.2%) DHAt 3 (1.3%) CMY-2 + DHA-1 1 (0.42%) P. mirabilis: CMY-2 2/204 (0.98%) Prevalence: 0.45% E. coli: 19/4360 (0.43%) CMY-2 17 (0.4%) CMY-57 1 (0.02%) DHA-1 1 (0.02%) K. pneumoniae: 7/785 (0.89%) CMY-2 5 (0.63%) DHA-1 2 (0.25%) IMP-22 9 (1.14%) VIM-1 1 (0.12%) P. mirabilis: CMY-2 5/230 (2.17%) Prevalence: 0.35% E. coli: 14/2956 (0.47%) CMY-2 13 (0.44%) CMYt 1 (0.03%) K. pneumoniae: DHA-1 + VIM-1 1/58 (1.72%) P. mirabilis: CMY-2 2/247 (0.81%) Prevalence: 0.62% E. coli: 13/4088 (0.32%) CMY-2 10 (0.24%) CMY-4 1 (0.02%) FOX-8 2 (0.05%) K. pneumoniae: CMY-2 1/357 (0.28%)

More Related